Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-13

Clinical Trial Update: Peanuts and Glycemic Control [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating peanut intake for glycemic control in type 2 diabetes with cardiovascular disease showed completed results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Penn State University | Conditions: Type2 Diabetes, Cardiovascular Diseases | Phase 2 | Status: COMPLETED | Results posted: 2022-05-13